Angélo Paci

Inserm — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

38h-index6.1kcitations449works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer, Hypoxia, and Metabolism(31), Acute Myeloid Leukemia Research(25), Adrenal and Paraganglionic Tumors(24), Cancer therapeutics and mechanisms(22), Cancer Treatment and Pharmacology(20)

Publications449 total

Evaluation of transplacental transfer and placental effects of two recommended melanoma targeted therapies
Placenta·2025
Pharmacogenetics in oncology: Unveiling its potential in treatment personalization and beyond
Bulletin du Cancer·2025
Safety and Efficacy of Intratumoral Anti-CTLA4 with Intravenous Anti-PD1
2025Open Access
Melanoma targeted therapies dabrafenib and trametinib cross the placental barrier in ex vivo human placental perfusions
Journal of the American Academy of Dermatology·2025
Nivolumab plasma concentration and clearance associated with overall survival in patients with renal cell carcinoma
Journal for ImmunoTherapy of Cancer·2025· 6 citedOpen Access
Elevated mortality risks associated with late diagnosis of cancer in individuals with psychiatric disorders?
Journal of Psychiatric Research·2024· 1 citedOpen Access
Sex differences in the pharmacokinetics of anticancer drugs: a systematic review
ESMO Open·2024· 22 citedOpen Access
Incidence and risk factors of graft failure in allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis in a nationwide pediatric cohort. A study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy
eJHaem·2024· 1 citedOpen Access
Prognostic value of total, free and lipoprotein fraction-bound plasma mitotane levels in advanced adrenocortical carcinoma: a prospective study of the ENDOCAN-COMETE-Cancer network
Journal of Endocrinological Investigation·2024· 2 citedOpen Access
“Cyclophosphamide and analogues; a matter of dose and schedule for dual anticancer activities”
Cancer Letters·2024· 13 cited
Tyrosine kinase inhibitors in cancers: Treatment optimization – Part II
Critical Reviews in Oncology/Hematology·2024· 8 citedOpen Access
Tyrosine kinase inhibitors in cancers: Treatment optimization – Part I
Critical Reviews in Oncology/Hematology·2024· 7 citedOpen Access
Management of Pain Medication in Patients With a History of Bariatric Surgery: A Systematic Review
Journal of Pain and Symptom Management·2024· 3 citedOpen Access
Gadolinium-based nanoparticles AGuIX and their combination with ionizing radiation trigger AMPK-dependent proinflammatory reprogramming of tumor-associated macrophages
2024· 2 citedOpen Access
36 Evaluation of transplacental transfer of cancer therapies in melanoma via the perfused human placental model
American Journal of Obstetrics and Gynecology·2024Open Access
Participation in an Italian cancer screening program among people with psychiatric diagnoses: a retrospective cohort study
Neuroscience Applied·2024Open Access
119 Transplacental transfer of alectinib and osimertinib using an ex vivo human placental perfusion model
American Journal of Obstetrics and Gynecology·2024Open Access
The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection
Frontiers in Immunology·2023· 17 citedOpen Access
Prognostic value of total, free and lipoprotein fraction-bound plasma mitotane levels in advanced adrenocortical carcinoma: a prospective study of the ENDOCAN-COMETE-Cancer network
2023· 1 citedOpen Access
Bevacizumab exposure and tumor response in patients with platinum resistant epithelial ovarian cancer.
Journal of Clinical Oncology·2023· 1 citedOpen Access
page 1 of 23Next →

Frequent Co-authors

Sophie Broutin(13), Alain Deroussent(7), Gilles Vassal(6), Nathalie Chaput(5), Gareth J. Veal(5), Olivier Mir(5), Philippe Bourget(5), Atmane Seck(4), Vianney Poinsignon(4), Sophie Leboulleux(4), Éric Baudin(4), Jacques Young(4), J Delahousse(4), Lionel Mercier(4), Ludovic Lacroix(3), Nicolas Widmer(3), Christophe Bardin(3), Étienne Chatelut(3), Jos H. Beijnen(3), Dominique Levêque(3)